Vernalis(VER)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Fledgling

Market Cap

£11.26m

Change Today

Price Up0.030p

Share Price

3.10p

EGM Statement

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008


VERNALIS PLC


RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008


Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.


All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.


Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1.    To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2.    To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3.    To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes


Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.


Document Viewing Facility

The Financial Services Authority

25 The North Colonade
Canary Wharf

London E14 5HS

Tel: 020 7066 1000


Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.


Enquiries:


Vernalis plc                                         +44 (0)118 977 3133

Tony Weir, Chief Financial Officer


Brunswick Group                                +44 (0)20 7404 5959

Jon Coles

Justine McIlroy


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).